InvestorsHub Logo
Followers 62
Posts 7549
Boards Moderated 1
Alias Born 01/02/2003

Re: Tatsumaki post# 408227

Friday, 05/05/2023 11:42:14 AM

Friday, May 05, 2023 11:42:14 AM

Post# of 425931
Tatsu...QUOTE..."why is Mochida and Sumitomo running P3 trials in China with it and not Amarin?"

Amarin is still waiting for approval for Vascepa in mainland China....
Future Chinese government approval for MND-2119 will allow Amarin and Mochida to continue their "COLLABORATION" and their "COMMERCIALIZATION" of this new drug in China as per their agreement.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News